Viral HepatitisNCT05207163
Continuing Medical Education to Improve Knowledge of Viral Hepatitis B-C in Primary Healthcare Workers
A study testing Continuing medical education in people with Viral Hepatitis, run by Pham Ngoc Thach University of Medicine at 1 site in Vietnam.
Trial summary
The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C Read more about this study
- Who is it for?
- Ages 24 to 65 yearsHealthy volunteers can take part
- Conditions the study is for
- Viral Hepatitis
- What is being tested?
- Continuing medical education
- Type of treatment
- Lifestyle or therapy programme
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 88 participants
- Where
- 1 siteVietnam
- Study dates
- 10 Feb 2022to Apr 2023
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 24 to 65 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Who may be able to join
- Currently working at Outpatient department, Primary-level hospitals
- Having Practicing Certificate
- Not attending any long-term education
- Accepting ICF
Who cannot join
- Not attending the full number of lessons
- Not answering the questionnaire
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Continuing Medical Education (CME) Intervention to Improve Knowledge About Viral Hepatitis B-C: A Randomized Controlled Trial Pilot at Primary-level Hospitals in Ho Chi Minh City
The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C
- Conditions
- Viral Hepatitis
- Being tested
- Continuing medical education
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Continuing medical educationBehavioural
Education section about knowledge of transmissions, severity of viral hepatitis B-C and update treatment strategy of the HBV-HCV
| Study group | Role | What they receive |
|---|---|---|
| Received CME | Experimental | Not described Receives: Behavioral: Continuing medical education |
| Not received CME | No intervention | Not described |
What is being measured
The primary outcome is the main question the study is designed to answer.
Change in Test Scores on Knowledge about Hepatitis B-C from Baseline to 6 months
Participants have exams pre- and post-6-months-course, which is multiple choice questions. The test score is average number of correct answers. The pre- and post-6-months exams use the same structure and questions. A change in test score is the difference between test score of the post-6-months-exam and test score of the pre-course-exam.
Measured: 6 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted26 Jan 2022
- Study start10 Feb 2022
- Primary completion10 Feb 2023 (estimated)
- Study completionApr 2023 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Viral HepatitisStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Enrolment
- 88 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Pham Ngoc Thach University of Medicine
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Le Hong Duc, Pham Ngoc Thach University of Medicine
- Investigators
- Lê H Đức, Medicine, Principal investigator, Pham Ngoc Thach University of Medicine
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05207163
- Sponsor's protocol ID
- 511/TĐHYKPNT-HĐĐĐ
- Status last verified
- Sep 2022
- First submitted
- 9 Dec 2021
- Last updated
- 30 Sep 2022
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided
Study at a glance
From the registry record, last updated by the sponsor on 30 Sep 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Continuing Medical Education (CME) Intervention to Improve Knowledge About Viral Hepatitis B-C: A Randomized Controlled Trial Pilot at Primary-level Hospitals in Ho Chi Minh City
- ClinicalTrials.gov ID
- NCT05207163
- Acronym / sponsor ID
- 511/TĐHYKPNT-HĐĐĐ
- Conditions
- Viral Hepatitis
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 88 participants (estimated)
- Lead sponsor
- Pham Ngoc Thach University of MedicineUniversity, hospital or other
- Study start
- 10 Feb 2022 (actual)
- Primary completion
- 10 Feb 2023 (estimated)
- Study completion
- Apr 2023 (estimated)
- First posted
- 26 Jan 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The purpose of study is identifying the effectiveness of 'continuing medical education' (CME) to primary healthcare worker to improve knowledge about viral hepatitis B-C
Study design
- Primary purpose
- Health services research
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- None (open label)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Received CME | Experimental | Behavioral: Continuing medical education |
| Not received CME | No intervention | – |
Who may qualify
- Ages
- 24 to 65 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
Key inclusion criteria (4 listed)
- Currently working at Outpatient department, Primary-level hospitals
- Having Practicing Certificate
- Not attending any long-term education
- Accepting ICF
Key exclusion criteria (2 listed)
- Not attending the full number of lessons
- Not answering the questionnaire
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Continuing medical educationEducation section about knowledge of transmissions, severity of viral hepatitis B-C and update treatment strategy of the HBV-HCV | Behavioural | Received CME |
Primary outcome
Change in Test Scores on Knowledge about Hepatitis B-C from Baseline to 6 months
Time frame: 6 months
Participants have exams pre- and post-6-months-course, which is multiple choice questions. The test score is average number of correct answers. The pre- and post-6-months exams use the same structure and questions. A change in test score is the difference between test score of the post-6-months-exam and test score of the pre-course-exam.
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 30 Sep 2022.
- Individual participant dataSharing planned: Undecided
Related trials for Viral Hepatitis
RecruitingObservational study
Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated Cirrhosis
Hepatitis D
Active, not recruitingPhase 2
A Study of Sequential Therapy With Daplusiran/Tomligisiran (DAP/TOM) Followed by Bepirovirsen in Participants Living With Chronic Hepatitis B (CHB)
Chronic Hepatitis B Virus Infection, Hepatitis B
RecruitingObservational study
Evaluation of Patients With Liver Disease
Hepatitis D, Hepatitis C
Active, not recruitingPhase 2
Study of Bepirovirsen in Participants Living With Human Immunodeficiency Virus and Chronic Hepatitis B Virus Infection (B-Focus)
Hepatitis B
Active, not recruitingPhase 2
Long-term Follow-up Study to Evaluate Durability of Treatment Response in Previous Bepirovirsen Study Participants (B-Sure)
Hepatitis B
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Lê H Đức, Medicine principal investigator
Pham Ngoc Thach University of Medicine
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Continuing medical education in people with Viral Hepatitis, run by Pham Ngoc Thach University of Medicine at 1 site in Vietnam.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 4 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 30 Sep 2022. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Vietnam. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Change in Test Scores on Knowledge about Hepatitis B-C from Baseline to 6 months (time frame: 6 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 30 Sep 2022.